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1. Introduction 
Foodborne diseases are a growing public health problem worldwide with Campylobacter and 
Salmonella being the most common and widely distributed causative agents. These Gram-
negative bacteria are common inhabitant of the gut of warm-blooded animals, especially 
livestock, being transmitted to humans primarily through the consumption of contaminated 
food of animal origin. Poultry meat and derivatives are regarded as the most common 
source of human salmonellosis and campylobacteriosis.  
In addition to the high prevalence of such pathogens and the consequent health problems 
caused, control of these pathogens has become increasingly difficult due to the emergence of 
antibiotic-resistant strains. This emergence is a result of the misuse of antimicrobials in food 
animals, compromising the action of once effective antibiotics in the treatment of foodborne 
diseases in humans.  
Recent legislation restricting the use of antibiotics as growth promoters in animal 
production, together with the risk of antibiotic-resistant bacteria entering the human food 
chain have been the driving force for the development of alternative methods for pathogen 
control. (Bacterio)phages are naturally occurring predators of bacteria, ubiquitous in the 
environment, with high host specificity and capacity to evolve to overcome bacterial 
resistance which makes them an appealing option for the control of pathogens. Several 
studies have been carried to assess the potential use of phages in the control of Campylobacter 
and Salmonella in animals and food material in order to prevent transmission of these 
pathogens to humans. Overall, although eradication of the target bacteria is an extremely 
unlikely event, the proof of principle, that phages are able to reduce the number of these 
pathogens has been established. Even so, some considerations should be taken into account 
for an efficient application of phages. 
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This chapter aims at giving an overview of the two major foodborne pathogens (Campylobacter 
and Salmonella), discussing the problems and concerns related to their prevalence and 
control, focusing mainly on the potential use of phages as an alternative to other control 
measures. Consequently, the successes and drawbacks of different studies on the use of 
phages to control Campylobacter and Salmonella will be explored. Moreover several aspects of 
phage biocontrol will be addressed. These include considerations on phage characterization, 
phage dose and route of administration, and ways of overcoming the emergence of phage 
resistant-bacteria. Finally the requisites for an acceptable phage product and the issues 
related to its public acceptance will be discussed. 
2. Foodborne diseases  
Foodborne diseases are of major concern worldwide. The Centres for Disease Control and 
Prevention (CDC) estimates that 76 million cases of foodborne diseases occur every year in the 
United States causing roughly 5000 deaths (Nyachuba, 2010). In Australia the number of cases 
(5.4 million) has been estimated to have an associated cost of 1.2 billion dollars per year 
(OzFoodNet Working Group, 2009). The European Food Safety Authority (EFSA) reported a 
total of 5,550 foodborne outbreaks, causing 48,964 human cases, 4,356 hospitalizations and 46 
deaths in 2009 (European Food Safety Authority, 2011). While significant attention is usually 
given to major foodborne outbreaks, studies indicate that outbreaks only account for a small 
fraction of Campylobacter and Salmonella infections in humans (European Food Safety 
Authority, 2009). While a steady decline in the number of cases attributed to Salmonella has 
been observed since 2004, the number of Campylobacter infections has remained constant 
(Figure 1). Campylobacteriosis caused 198,252 confirmed human cases in 2009 with a fatality 
rate of 0.02 %, continuing to be the most commonly reported zoonosis in the European Union. 
A total of 108,614 confirmed human cases were attributed to Salmonella with a fatality rate of 
0.08 % in the same year. Moreover there is a considerable underreporting, and the true number 
of cases of illness caused by these two pathogens is likely to be 10-100 times higher than the 
reported number (European Food Safety Authority, 2011). 
 
Fig. 1. Number of reported campylobacteriosis and salmonellosis cases in humans 2001-2009 
(European Food Safety Authority, 2006; European Food Safety Authority, 2011) 
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2.1 The pathogens 
2.1.1 Campylobacter 
Campylobacter was first described in 1880 by Theodore Escherich and belongs to the 
Epsilonproteobacteria, in the order Campylobacterales which includes Helicobacter and 
Wolinella (Friedman et al., 2000; Keener et al., 2004). The name Campylobacter is derived from 
the Greek “kampulos” = curved and “bacter” = rod. In fact, bacteria belonging to the genus 
Campylobacter are non-spore forming, oxidase-positive, Gram-negative, curved or spiral 
(occasionally straight) rods with 0.2 µm to 0.8 µm wide and 0.5 µm to 5 µm long. When they 
form short or long chains they can appear as S-shaped, V-shaped or more rarely comma 
shaped. Campylobacter ssp. usually displays a long unsheathed polar flagellum at one (polar) 
or both (bipolar) ends of the cell which confer to this microorganism a rapid, darting and 
reciprocating motility (Keener et al., 2004). Campylobacter spp. cells tend to form coccoid and 
elongated forms on prolonged culture or upon exposure to oxygen (Moran & Upton, 1987). 
These cells may be associated to a viable but not culturable state (VBNC). However the 
association between cell culturability and cell morphology remains controversy (Keener et 
al., 2004). 
The genus Campylobacter now comprises 17 member species. The most commonly isolated 
are C. jejuni ssp. jejuni, C. coli and C. lari which are referred as thermophilic species. They can 
grow at 37ºC to 42ºC with a pH in the range of 4.9 to 9.0, but their optimum growth 
conditions include a temperature of 42ºC and a pH of 6.5 to 7.5. It is known that they cannot 
multiply below 30ºC and that they require a microaerobic atmosphere (approximately 5% 
oxygen and 10% carbon dioxide) (Butzler, 2004). 
Contrary to most bacteria, Campylobacter species do not obtain their energy from the 
metabolism of carbohydrates but instead from amino acids or tricarboxylic acid cycles 
intermediates. C. jejuni hydrolyzes hippurate and indoxyl metabolizes acetate and reduces 
nitrate (Butzler, 2004). 
2.1.2 Salmonella 
Investigations on the etiologic agent of the “swine plague” led Theobald Smith, in 1885, to 
the isolation of a Gram-negative bacillus named Bacterium suipestifer. The bacterium was 
further characterized by D. E. Salmon from whom the name Salmonella is derived. The non-
spore forming cells possess a straight rod-shaped morphology with sizes varying from 0.7 
µm to 1.5 µm in diameter and 2 µm to 5 µm in length. These cells are usually motile 
presenting peritrichous flagella. Salmonella spp. belong to the Enterobacteriaceae family and 
are chemoorganotrophs (organisms which use organic compounds as their energy source), 
facultative anaerobes and hydrogen sulphide producers (Bell & Kyriakides, 2002). 
The outer membrane (OM) of Salmonella, as with almost all Gram-negative bacteria, is 
composed of OM proteins (OMPs) and lipopolysaccharides (LPS). LPS plays an essential 
role in maintaining the cell structural integrity and protection from chemicals. In the host 
organisms they act as endotoxins and as a pyrogen displaying a strong immune response. 
Structurally they are composed by three distinct components: lipid A, core oligosaccharide 
and O-polysaccharide (Raetz & Whitfield, 2002). The O-polysaccharide (also O-antigen or O-
side-chain) together with the H-antigen (from flagella) and Vi (capsular antigens) are the 
basis for the Kauffman-White classification scheme, enabling the different Salmonella to be 
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grouped in serotypes according to their agglutination pattern when reacted with specific 
commercial antisera (Bell & Kyriakides, 2002; Brenner et al., 2000). This classification led to 
the recognition of more than 2500 serotypes (Bell & Kyriakides, 2002), a number that 
increases every year. A revision of the nomenclature has established two species  (S. enterica 
and S. bongori) with the majority of the serotypes grouped into one of the six Salmonella 
subspecies of S. enterica (Bell & Kyriakides, 2002; Brenner et al., 2000; Velge et al., 2005). 
2.2 The diseases 
Campylobacter and Salmonella are common inhabitant of the gut of warm-blooded animals 
mainly livestock (such as cattle, sheep, pigs and chickens), domestic pets and wild animals, 
where they asymptomatically colonize and multiply (Antunes et al., 2003; Bell & Kyriakides, 
2002; Bryan & Doyle, 1995; Doyle & Erickson, 2006; Newell & Fearnley, 2003). As zoonotic 
agents, Campylobacter and Salmonella can be transferred between humans and other animals. 
The common route of these pathogens is the consumption of contaminated food of animal 
origin, particularly meat from pigs, cattle and poultry (and derivatives) and milk. Poultry 
and derivatives are repeatedly pointed out as the most common sources of infection since 
the pathogens are present at a high level in fresh poultry meat. Campylobacter and Salmonella 
strains may also reach humans via routes other than food, directly by the contact with 
contaminated animals, carcasses or the environment, for example, through drinking water 
(European Food Safety Authority & European Centre for Disease Prevention and Control, 
2011). Therefore, horizontal transmission appears to have a major role in the transmission of 
these foodborne pathogens. In contrast to Salmonella, vertical transmission of Campylobacter 
is generally considered a relatively unimportant route of flock colonization with the 
consequent general absence of Campylobacter in eggs, one of the most common routes of 
contamination by Salmonella (European Food Safety Authority, 2011; Newell & Fearnley, 
2003). 
These microorganisms have the ability to survive for considerable periods, especially in 
conditions that are moist, cool and out of direct sunlight. As a result, they can readily 
contaminate other hosts, as for example, humans where Campylobacter infection is usually 
associated with illness and for which doses as low as 500 organisms have been reported to 
cause gastrointestinal disorders (Friedman et al., 2000; Newell & Fearnley, 2003; Robinson, 
1981). As a consequence, bird-to-bird transmission within flocks is very rapid and it was 
demonstrated that once a broiler flock becomes infected with Campylobacter, close to 100% of 
birds are reported to become colonized in a very short time (Allen et al., 2007; Newell & 
Fearnley, 2003). Moreover it is known that, after in vivo-passage, organisms can exhibit an 
enhancement of colonization potential of at least 1,000-fold in most strains and up to 10,000-
fold in some strains (Berndtson et al., 1992; Keener et al., 2004). The most important 
Campylobacter species associated with human infections are C. jejuni, C. coli, C. lari and C. 
upsaliensis (European Food Safety Authority, 2011; Friedman et al., 2000; Robinson, 1981). 
Campylobacter has become the most recognized antecedent cause of Guillain-Barré syndrome 
(GBS), an acute post-infectious immune-mediated disorder affecting the peripheral nervous 
system that can be permanent, fatal or last several weeks and usually requires intensive care 
(Butzler, 2004; Nachamkin, 2002). 
The factors contributing for the high prevalence of these pathogens in poultry meat are bad 
slaughter conditions, cross-contamination, inadequate heat treatment, raw meat and 
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inappropriate food storage (European Food Safety Authority, 2011; Gorman et al., 2002; 
Hansson et al., 2005; Jacobs-Reitsma, 2000; Johannessen et al., 2007; Luber et al., 2006; van de 
Giessen et al., 2006). A European Union-wide baseline survey on Campylobacter demonstrated 
that in EU 71.2% of broilers are colonized by Campylobacter at the slaughterhouse (European 
Food Safety Authority, 2010). Therefore, controlling Campylobacter and Salmonella infections 
has become an important goal particularly for the poultry industry. 
Human infection by these pathogens results in a gastrointestinal infection, which is usually 
characterized by an inflammatory reaction, watery (sometimes bloody) diarrhoea, fever, 
vomiting, abdominal cramps and dehydration which can become severe and life-threatening 
as a result of tissue invasion and toxin production (Bell & Kyriakides, 2002; Butzler, 2004; 
Friedman et al., 2000; Nachamkin, 2002; Uzzau et al., 2000). Salmonella infections are 
influenced by the bacterium’s host range or degree of host adaptation, enabling the division 
of the bacteria in two groups: host adapted and ubiquitous. The higher the adaptation of 
Salmonella to a host, the higher the pathogenicity, with a consequent severity of the disease, 
usually leading to septicaemia (Bell & Kyriakides, 2002; Uzzau et al., 2000; Velge et al., 2005). 
The most prevalent and important Salmonella enterica serotypes reported worldwide are 
Enteritidis and Typhimurium. These are responsible for 99% of salmonellosis in humans 
and warm-blooded animals (Bell & Kyriakides, 2002; Brenner et al., 2000). 
2.3 Antibiotic resistance 
Antibiotics were introduced in the 1940s and have been widely used in the United States 
(US) and Europe (EU) in livestock and poultry since the 1950s. In the US at least 17 
antimicrobials were approved to be used in food animals. In Europe, all classes of antibiotics 
licensed for human medicine were allowed for use in animals. As a consequence, antibiotics 
were used in food animals therapeutically, prophylactically and as food supplements to 
promote faster growth by improving feed efficiency. The discovery of antibiotics growth-
enhancing effect became an important element of intense animal husbandry leading to their 
increased use, often in sub-therapeutic doses in healthy animals and without veterinary 
prescription (Castanon, 2007; Mathew et al., 2007; Sapkota et al., 2007; World Health 
Organization, 2002). 
The amount of antibiotics used in the absence of disease for non-therapeutic purposes in 
livestock far exceeds the amount of antimicrobials used in human medicine. It was 
estimated that 60 to 80% of the antibiotics produced in the US is used for this purpose. The 
use of antibiotics in livestock has become a major source of concern because of the 
possibility that they contribute to the declining efficacy of antibiotics used to treat bacterial 
infections in humans (Smith et al., 2002). This may happen because antimicrobial agents 
used for food-producing animals are frequently the same or belong to the same classes as 
those used in human medicine. The later includes tetracyclines, macrolides and 
fluoroquinolones (Aarestrup et al., 2008; Mellon et al., 2001; Sapkota et al., 2007). 
Two EU agencies, the European Food Safety Authority (EFSA) and the European Centre for 
Disease Prevention and Control (ECDC), reported recently on the high incidence of 
antibiotic resistance in Salmonella and Campylobacter, and stated their concern. In fact, the 
high percentage of Salmonella and Campylobacter isolates displaying resistance to 
ciprofloxacin is alarming since it represents one of the drugs of choice in human treatment. 
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High resistance of Salmonella to tetracyclines, ampicillin and sulphonamides was also 
reported, as was Campylobacter resistance to high levels of tetracyclines. The EFSA report 
concluded that the animal antimicrobial usage might be an important factor accounting for 
the high proportion of resistant isolates (European Food Safety Authority, 2011; European 
Food Safety Authority & European Centre for Disease Prevention and Control, 2011; Gyles, 
2008; Rabsch et al., 2001). 
The resistance problem has led the World Health Organization (WHO) in 2002 to advise and 
encourage all countries to reduce the use of antibiotics outside human medicine and has 
already established some measures in the surveillance of foodborne diseases in order to 
reduce the emergence of resistant bacteria with special concern for Salmonella and 
Campylobacter (Smith et al., 2005; World Health Organization, 2002). This concern was 
already present in the EU where several countries have banned the use of antimicrobials 
that are used in human medicine as growth promoters. The consequent reduction of the 
selective pressure, has already resulted in a reduction of antimicrobial resistance in a 
national population of food animals (Aarestrup et al., 2001; Castanon, 2007; Emborg et al., 
2003; Smith et al., 2005; Swann, 1969; Tacconelli et al., 2008; Wierup, 2001; World Health 
Organization, 2002).  
Antibiotics are usually the last resource in pathogens control leaving no hope in the 
treatment of multiresistant bacteria for which no effective antimicrobial exists. 
Consequently, it can be concluded that an efficient alternative to antibiotics is critical and 
urgent. In order to control foodborne pathogens, the poultry industry decontaminates 
carcasses using both chemical and physical treatments. Chemical treatments include 
washing of carcasses in electrolyzed or chlorinated water, dipping carcasses in a solution 
containing acidified sodium chlorite before chilling, immersion in acetic or lactic acid or in 
sodium triphosphate solutions. Physical treatments include freezing of contaminated 
carcasses, heat-treatment of fresh broiler carcasses, dipping of fresh carcasses in hot water 
immediately before chilling, radiation, exposure to dry heat, and ultrasonic energy in 
combination with heat (Corry & Atabay, 2001; Keener et al., 2004). In spite of the effort that 
has been done to control these pathogens, they are still a major cause of foodborne diseases 
(European Food Safety Authority, 2011; Nyachuba, 2010)(Figure 1). 
Other possible control measures to eliminate or reduce the contamination of birds are still 
being developed and their cost-effectiveness and applicability to large-scale production 
remain to be determined. It includes: vaccination, the use of competitive exclusion, 
improving genetic resistance of birds and the use of probiotics, bacteriocins and 
bacteriophages (Chen & Stern, 2001; García et al., 2008; Joerger, 2001). 
3. Bacteriophages: Novel therapeutic agents 
(Bacterio)phages are viruses that are able to infect Bacteria. Phages are able to infect more 
than 150 bacterial genera, including aerobes and anaerobes, exospore and endospore 
formers, cyanobacteria, spirochetes, mycoplasmas, and chlamydias (Ackermann, 2001; 
Ackermann, 2009). 
Structurally they consist of a nucleic acid genome enclosed within a protein or lipoprotein 
coat and like all viruses are absolute parasites, inert particles outside their hosts, deprived of 
their own metabolism. Inside their hosts, phages are able to replicate using the host cell as a 
Phages as Therapeutic Tools  
to Control Major Foodborne Pathogens: Campylobacter and Salmonella 
 
185 
factory to produce new phages particles identical to its ascendant, leading to cell lysis and 
consequent death of the host (Guttman et al., 2005). As a result of their bacterial parasitism, 
phages can be found wherever bacteria exist and have already colonized every conceivable 
habitat. Phages are an extremely diversified group and it has been estimated that ten phage 
particles exist for each bacterial cell. This fact accounts for an estimated size of the global 
phage population to be approximately 1031 particles making phages the most abundant 
living entities on earth (Rohwer, 2003). 
Their presence in the biosphere is especially predominant in the oceans presenting an excess 
of 107 to 108 phage particles per millilitre in coastal sea and in non-polluted water and 
comparably high numbers in other sources like sewage and faeces, soil, sediments, deep 
thermal vents and in natural bodies of water (Rohwer, 2003). In the absence of available 
hosts to infect, and as long as they are not damaged by external agents, phages can usually 
maintain their infective ability for decades (Guttman et al., 2005; Sharp et al., 1986). 
3.1 Phage therapy versus chemotherapy  
Phage therapy presents many potential advantages over the use of antibiotics which are 
intrinsic to the nature of phages. Phages are highly specific and very effective in lysing the 
target pathogen, preventing dysbiosis, that is, without disturbing the normal flora and thus 
reducing the likelihood of super-infection and other complications of normal-flora reduction 
that can often result following treatment with chemical antibacterials. This high specificity 
means that diagnosis of the bacteria involved in the infection is required before therapy is 
employed (Guttman et al., 2005; Marks & Sharp, 2000; Matsuzaki et al., 2009). The specificity 
of phages also enables their use in the control of pathogenic bacteria in foods since they will 
not harm useful bacteria, like starter cultures. Moreover, phages do not affect eukaryotic 
cells, or cause adverse side effects as revealed through their extensive clinical use in the 
former Soviet Union. Furthermore, phages are equally effective against multidrug-resistant 
pathogenic bacteria.  
It was also found that phages can rapidly distribute throughout the body reaching most 
organs including the prostate gland, bones and brain, that are usually not readily accessible 
to drugs and then multiply in the presence of their hosts (Dabrowska et al., 2005). The self-
replicating nature of phages reduces the need for multiple doses to treat infection diseases 
since they will replicate in their pathogenic host increasing their concentration over the 
course of treatment leading to a higher efficacy. This also implies that phages will be present 
and persist at a higher concentration where their hosts are present, which is where they are 
more needed, in the place of infection. Reciprocally, where and if the target organism is not 
present the phages will not replicate and will be removed from the system showing the 
other side of the self-replicating nature of phages, their self-limiting feature (Goodridge & 
Abedon, 2003; Petty et al., 2007). 
As it happens with antibiotics, bacteria also develop resistance to phages. The latter usually 
occurs through loss or modification of cell surface molecules (capsules, OMPs, LPS, pili, 
flagella) that the phage uses as receptors. Since some of these also function as virulence 
determinants their loss may in consequence dramatically decrease the virulence of the 
bacterium or reduce its competitiveness (Levin & Bull, 2004). A good example is that of 
Smith (1987) that used phages against the K1 capsule antigen of Escherichia coli and verified 
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that resistant K1 bacteria were far less virulent (Smith et al., 1987b). Furthermore, different 
phages binding to the same bacteria may recognize different receptors and resistance to a 
specific phage does not result in resistance to all phages. Phages are able to rapidly change 
in response to the appearance of phage-resistant mutants making them efficient in 
combating the emergence of newly arising bacterial threats (Matsuzaki et al., 2009; 
Sulakvelidze et al., 2001). In addition, the isolation of a new phage able to infect the resistant 
bacteria can be easily accomplished. It is much cheaper, faster and easier to develop a new 
phage system than a new antibiotic which is a long and expensive process (Petty et al., 2007).  
4. Phage potential in food safety 
Phages can be used to combat pathogens in food at all stages of production in the classic 
‘farm-to-fork’ continuum in the human food chain (García et al., 2008). Accordingly, in order 
to prevent transmission to humans, phages can be used:  
i. in livestock to prevent diseases or reduce colonization;  
ii. in food material (such as carcasses and other raw products) or in equipment and contact 
surfaces to reduce bacterial loads; 
iii. in foods as natural preservatives to extend their shelf life.  
Several studies have been carried to assess the potential use of phages in the control of 
Campylobacter and Salmonella in animals and foodstuff. Although very different results have 
been obtained it seems that the proof of principle has been established: phage therapy has 
potential in the control of foodborne pathogens (Johnson et al., 2008). The large scale, high 
throughput and mechanization of poultry production and industry, made poultry and 
products the most commonly used models for phage biocontrol (Atterbury, 2009). This is 
reflected in the studies that will be addressed below. 
4.1 Campylobacter and Salmonella phages 
4.1.1 Campylobacter 
There are relatively few reports on Campylobacter phages probably due to the fastidious 
growth conditions of their host and to unique features that their phages exhibit. This has 
hindered the use of conventional methods of phage isolation, propagation and 
characterization (Bigwood & Hudson, 2009; Tsuei et al., 2007). Recently Carvalho et al. (2010) 
described an improved method for Campylobacter phage isolation in which a pre-enrichment 
of the phages with potential host strains supplemented with divalent cations was used to 
promote phage adherence to the host (Carvalho et al., 2010b). Campylobacter-specific phages 
have been isolated from excreta of both broiler and layer chickens, retail poultry, and other 
sources including pig, cattle and sheep manure, abattoir effluents, and sewage (Connerton et 
al., 2011). Some of these phages have been characterized and form the basis of the United 
Kingdom phage typing scheme (Frost et al., 1999; Sails et al., 1998). 
The most frequently encountered Campylobacter phages belong to Caudovirales order, 
Myoviridae family with a double-stranded DNA genome enclosed in icosahedral heads 
(Connerton et al., 2008). Campylobacter phages have been characterized into three groups 
according to their genome size and head diameter (Sails et al., 1998): Group I - head 
diameters of 140 nm – 143 nm and large genome sizes of 320 kb; Group II - average head 
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diameters of 99 nm and average genome sizes of 184 kb; Group III - average head diameters 
of 100 nm and average genome sizes of 138 kb. Hansen et al. (2007) characterized 
Campylobacter phages according to their genome size and susceptibility of digestion by HhaI 
(Hansen et al., 2007). 
The DNA of most Campylobacter phages is difficult to extract, clone and sequence and is 
refractory to restriction enzyme digestion, which is probably due to tightly adherent and 
proteinase K resistant proteins (Carvalho et al., 2011; Hammerl et al., 2011; Kropinski et al., 
2011; Timms et al., 2010). As a consequence, the genome sequence of only five Campylobacter 
phages have been reported so far (Carvalho et al., 2011; Hammerl et al., 2011; Kropinski et al., 
2011; Timms et al., 2010). Interestingly, the phage genomes known are all related and also 
part of the T4 superfamily of phages (Petrov et al., 2010). 
There is little information available regarding the prevalence and influence of phages on 
Campylobacter-colonized poultry flocks. In fact, the prevalence of Campylobacter phages in 
poultry has essentially only been described in the UK. It was reported that C. jejuni phages 
were isolated from 20% of the caeca of chickens sampled in which there was a correlation 
between the presence of natural environmental phages and a reduction in the numbers of 
colonizing Campylobacter. Interestingly, birds that harbored phages had a significant 
difference (P < 0.001) in Campylobacter colony forming units (CFU) per gram in relation to 
those that did not have phages (Atterbury et al., 2005). Campylobacter phages were prevalent 
in the caecal contents of organic birds with 51% of Campylobacter-positive sampled birds also 
carrying phages. The higher value of phage positive samples in organic flocks can be 
explained by the fact that these birds are more exposed to the environment and therefore to 
a greater range of Campylobacter types and phages (El-Shibiny et al., 2005). 
It was also showed that, like Campylobacter, their phages are also transferred between flocks 
(Connerton et al., 2004). Moreover, phages were also recovered from chilled retail poultry, 
meaning that these phages can survive on retail chicken under commercial storage condition 
(Atterbury et al., 2003b). 
4.1.2 Salmonella 
Numerous phages infecting Salmonella have been isolated. The first report of a Salmonella 
phage dates back to 1918 and was described by Félix d’Hérelle. Since then, Salmonella 
phages have been isolated from different sources: wastewater plants, sewage, manure, 
faeces and caecal contents from different animals (e.g. poultry, turkey, pig, humans), zoo 
ponds, nests from poultry farms and many others (Andreatti Filho et al., 2007; Santos et al., 
2010; Sillankorva et al., 2010). The search for different Salmonella phages from different 
sources may be attributed to the interest prompted by the medical and veterinary 
significance of their pathogenic host. 
The great number and different specificity of Salmonella phages has enabled Salmonella 
classification through phage typing, a useful typing tool for subcategorizing the more 
common Salmonella enterica serotypes (i.e. S. Typhimurium, S. Enteritidis, S. Heidelberg) 
recommended by the WHO.  
Probably the best known Salmonella phages are the lytic phage Felix 01 and the temperate 
virus P22. Felix 01 is characterized by its broad lytic spectrum among Salmonella and has 
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been used as a diagnostic tool in the identification of Salmonella. Recently, a phage with a 
broader host range than Felix 01 has been described which presents great potential not only 
as a therapeutic agent but also as a diagnostic tool (Santos et al., 2010; Santos et al., 2011; 
Sillankorva et al., 2010) (Figure 2). 
 
Fig. 2. TEM observation of the broad host range myovirus Salmonella phage PVP-SE1 (Santos 
et al., 2010) 
A survey conducted by Ackermann identified 177 Salmonella phages of which 91% belong to 
the Caudovirales order. Their distribution by families is roughly equal with 24% Myoviridae, 
31% Siphoviridae and 33% Podoviridae. The 9% left are distributed in the Inoviridae, Leviviridae, 
Microviridae, and Tectiviridae families (Ackermann, 2007). A phylogenetic analysis relying on 
a proteomic comparison resulted in the recognition of at least five groups: P27-like, P2-like, 
lambdoid, P22-like, and T7-like. Nevertheless, three Salmonella phages (epsilon15, KS7, and 
Felix O1) are outliers since they could not be attributed to any of the previous groups 
(Kropinski et al., 2007). 
4.2 Phage biocontrol in livestock 
As already outlined above, contamination of meat products with Campylobacter and 
Salmonella, as well as other foodborne pathogens, often results from cross-contamination 
between carcasses and feces from infected animals during slaughter and processing and also 
during transportation, leading to an increase of bacterial loads. Phage biocontrol in livestock 
presents two major purposes: i) treatment of bacterial pathogens in animals to minimize its 
impact on animal health and production and, ii) control of foodborne pathogens 
contamination to humans through foodstuff or other vectors. Therefore, the use of phages to 
control pathogens in livestock seems to be a feasible and efficient approach.  
In this chapter the term phage therapy will refer only to the use of phages to control 
bacterial infections in living animals, whereas, the term biocontrol will be used where 
phages control pathogens in animals and foodstuff (independent of infection) (Hagens & 
Loessner, 2010). 
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4.2.1 Campylobacter  
There are only a few reports on phage biocontrol against Campylobacter-infected livestock, 
with all the studies being conducted on poultry. Wagenaar et al. (2005) assessed both 
preventive and therapeutic phage treatment (Wagenaar et al., 2005). In their study, multiple 
doses of a group III phage were administered to chicks before or after being orally 
challenged with a C. jejuni strain. In order to access the effect of phage administration on 
broilers, the Campylobacter colony forming units (CFU) and the phage plaque forming units 
(PFU) from caecal contents were enumerated throughout the experimental period. These 
values were obtained from the group receiving phages and from the control group (in which 
birds did not received phages). In both treatments, birds were orally challenged with a dose 
of 1X105 CFU C. jejuni ten days after hatching. Preventive treatment consisted in the oral 
administration of phage 71 (4X109 to 2X1010 PFU) for ten consecutive days, starting seven 
days after hatching. The phage treatment did not prevent the colonization of the caecum, 
but may had delayed it. In fact, initially the numbers of Campylobacter were reduced by 2 
log10 CFU/g but after one week the numbers leveled out at approximately 1 log10 below that 
of the controls. In the therapeutic treatment the phage was orally administrated five days 
after birds being challenged with C. jejuni and consecutively during the next six days. The 
numbers of Campylobacter had decreased 3 log10 CFU/g at 48h, but after five days stabilized 
to approximately 1 log10 CFU/g below the control group. In order to mimic the “farm 
condition” in which birds are normally slaughter at 42 days, birds were orally challenged 
with a dose of 1X105 CFU C. jejuni at 32 days after hatching. Seven days later phages 71 and 
69 were orally administered to these birds and for four consecutive days. As occurred with 
the previously described treated group, the values of Campylobacter counts dropped initially 
1.5 log10 CFU/g but then stabilized at 1 log10 unit lower than in the controls. 
In the study by Loc Carrillo et al. (2005), broiler chicks at 20 to 22-day-old were challenged 
with C. jejuni strains isolates HPC5 and GIIC8 from United Kingdom broiler flocks that have 
proved to be good colonizers (Loc Carrillo et al., 2005). The chicks received four different 
doses of HPC5 (2.7 log10 CFU, 3.8 log10 CFU, 5.8 log10 CFU and 7.9 log10 CFU) and after 48h 
the Campylobacter numbers in the caeca, upper and lower intestine were enumerated. The 
highest dose led to more reproducible colonization levels of all intestinal sites examined, 
with a mean value of 6.3 log10 CFU/g, 6.7 log10 CFU/g and 7.4 log10 CFU/g in the upper 
intestine, lower intestine and caeca respectively. Moreover these colonization levels, which 
are similar to those of naturally colonized birds (Rosenquist et al., 2006), were maintained 
over nine days. The phage treatment occurred five days after the C. jejuni challenge. Birds 
were treated orally with two phages (CP8 or CP34) independently at a dose of 105, 107 or 109 
PFU. The phages were administered in an antacid suspension (CaCO3) since it proved to 
protect phages from exposure to low pH during passage through the gastrointestinal tract. 
The administration of 107 PFU was the dose which led to the highest reduction (3.9 log10 
CFU/g) in the upper and lower intestine and caecal counts of Campylobacter at 24 h. The 
highest dose was less effective in the treatment probably due to the aggregation and 
nonspecific association of phages with digesta, non-host bacteria or bacterial cell debris 
resulting from “lysis from without” (Rabinovitch et al., 2003). Different host-phage 
combinations were tested in vivo, leading to different results. In fact, and contrarily to the 
results obtained in vitro, phage CP34 was more effective in the reduction of C. jejuni HPC5 at 
all intestinal sites compared to CP8. Conversely phage CP8 was efficient in the reduction of 
Campylobacter counts by more than 5 log10 CFU/g in caecal Campylobacter counts. Despite 
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this initial reduction, the C. jejuni numbers started to increase 72 h after phage 
administration with the lower intestinal counts exhibiting significant differences of 2.1 log10 
and 1.8 log10 CFU/g but with the upper intestinal counts showing no significant difference 
with the Campylobacter levels recorded for the control group. 
El-Shibiny et al. (2009) reported the administration of a group II Campylobacter phage (CP220) 
to C. coli and C. jejuni colonized chickens (El-Shibiny et al., 2009). The results showed that a 2 
log10 CFU/g reduction in Campylobacter counts was observed when a single 107 or 109 PFU 
dose of CP220 was administered to C. jejuni or C. coli colonized chickens, respectively. After 
this treatment, only 2% of the recovered Campylobacter displayed resistance to CP220.  
Recently, Carvalho et al. (2010) tested a phage cocktail composed by three group II 
Campylobacter phages (Figure 3) in chicks that were previously challenged with C. coli strain 
A11 or C. jejuni strain 2140 (Carvalho et al., 2010a). Again, colonization models were 
established before phage therapy experiments were performed in order to access the 
effective reduction in Campylobacter numbers. In order to determine the optimum dose of 
Campylobacter that should be given to birds, the animals were challenged with three 
different concentrations (104, 106 or 5.5×107 CFU) of an overnight culture of C. jejuni and 
sampling points were obtained during seven days. The results obtained revealed that the 
dose of Campylobacter appeared to have little effect on the outcome of subsequent 
colonization and that the mean level of colonization was 2.4×106 CFU/g, which is within the 
range of the infection levels found in commercial broilers (Rosenquist et al., 2006). Seven 
days post-infection, a single dose of a phage cocktail was administered to chicks by two 
different routes: oral gavage and incorporated into their feed. Sampling points were taken 
for seven days after phage administration and showed that the phage cocktail was able to 
reduce by approximately 2 log10 CFU/g the titre of both C. coli and C. jejuni in faeces of 
colonized chickens. This reduction persisted throughout the experimental period and none 
of the pathogens regained their former numbers. The administration in feed led to an earlier 
and more sustainable reduction of Campylobacter than administration by oral gavage. The 
phage titers from faecal samples of the chicks infected with Campylobacter remained 
approximately constant throughout the experimental period showing that phages delivered 
to chicks (either by oral gavage or in feed) were able to replicate and therefore able to reduce 
the Campylobacter populations. 
 
Fig. 3. TEM observation of the three Campylobacter phages, belonging to the family 
Myoviridae, which make up the cocktail used in the in vivo experiments by Carvalho et al. 
(2010): a) phiCcoIBB12, b) phiCcoIBB35, c) phiCcoIBB37 (Carvalho et al., 2010a) 
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The appearance of phage resistant mutants has always been seen as a major drawback of 
phage therapy. Nevertheless some of the above mentioned studies found that phage 
resistance can be associated with a reduced colonization potential in the chicken intestine, 
suggesting that there is a fitness cost to phage resistance in which phage-resistant 
Campylobacter revert to a sensitive phenotype when re-colonizing the chicken intestine in the 
absence of phage predation. It was also suggested that genomic instability of C. jejuni in the 
avian gut can be seen as a mechanism to temporarily survive phage predation and later 
competition for resources (Carvalho et al., 2010a; Loc Carrillo et al., 2005; Scott et al., 2007a; 
Scott et al., 2007b). Conversely, recent studies by Carvalho et al. (2010) reported that 
Campylobacter strains resistant to phage infection were recovered from phage-treated 
chickens at a frequency of 13% and that these resistant phenotypes did not exhibit a reduced 
ability to colonize the chicken guts and did not revert to sensitive types (Carvalho et al., 
2010a). 
4.2.2 Salmonella  
The importance and impact of Salmonella has elicited several studies on the use of phages on 
the control of this pathogen. Although poultry represents the most commonly used models, 
studies also exist in pigs. 
In 1991, Berchieri and colleagues used a chicken model to assess the potential of phages to 
control Salmonella Typhimurium in chickens. In the established model, oral infection with 
109 CFU of Salmonella was fatal in 53% of the chickens. Oral administration of phage at high 
concentration (greater than 1010 PFU/ml), soon after Salmonella infection, was able to 
significantly reduce mortality (from 60% to 3%) as well as the number of pathogens in the 
alimentary tract. The high dose required for the reduction of Salmonella suggests that control 
by the phage was made by “lysis from without” or by a single cycle of replication. Although 
pathogen numbers were reduced shortly after phage administration, they increased soon 
after. Moreover, the phage was only present in the intestine when Salmonella was found in 
numbers above 106 CFU/ml (Berchieri et al., 1991). Therefore, an efficient application of the 
phage required that administration should be right after infection and even so bacterial 
control was possible only for a short period. This may be attributed to the ability of 
Salmonella to internalize cells thus escaping from phages. As with the Campylobacter studies 
(see above) phage resistant bacteria were also found to present rough morphology and to 
display less virulence than the wild strain. More than one phage was used in this study and 
one of these, although lytic in vitro, was not effective in vivo showing the importance of in 
vivo trials.  
Fiorentin et al. (2005) used a cocktail of three phages to control S. Enteritidis PT4 in broilers. 
The phage dose administered was also very high (1011 PFUs of each phage). In this study 
phage was administered only seven days post infection and a 3.5 log10 CFU reduction per 
gram of caecal content was recorded five days later. This level remained for 25 days. It seems 
here that time of administration was not critical but phage dose was. Although a high dose 
and a cocktail of phages were used with the purpose of reducing the possibility of phage 
resistant bacteria emergence, the presence of such cells was not assessed (Fiorentin et al., 2005). 
When a similar dose (1011 PFUs) was given orally two days after infection, Atterbury et al. 
(2007) were able to achieve a reduction of the caecal colonization of both S. Enteritidis and S. 
 
Bacteriophages 
 
192 
Typhimurium in broiler chickens by up to 4.2 log10 CFU/g. Lower doses were ineffective in 
achieving similar results. A third phage tested in this study against S. Hadar did not reduce 
bacterial counts despite its strong lytic activity in vitro against that strain. The emergence of 
resistant bacteria was here also a reality with the number of phage resistant Salmonella 
increasing with the PFUs administered. This subpopulation of resistant bacteria was able to 
recolonize the broiler chickens within 72 hours after phage treatment. Interestingly, when 
these resistant bacteria were used to colonize a new group of chickens, they reverted to their 
phage-sensitive phenotype (Atterbury et al., 2007). 
Borie et al. (2008) pretreated ten day old broiler chicks, by coarse spray or drinking water 
containing a cocktail of three phages 24 hours before administering roughly 106 CFUs of 
Salmonella Enteritidis (calculated multiplicity of infection (MOI) of 103). After ten days of 
infection phages were recovered from the intestinal and other organs. A significant 
reduction in Salmonella Enteritidis was obtained at that time for both routes of 
administration with a reduction of more than 1 log10 CFU/ml in challenged bacterial 
numbers. This study demonstrates not only that phages are able to reduce Salmonella 
bacterial loads in broiler chickens but also that aerosol spray and drinking water are 
conceivable routes of administration in the application of a phage product which will surely 
facilitate application and establishment of phage biocontrol in an industrial environment 
(Borie et al., 2008). In a later study these authors, using  seven days old  chicks were able to 
replicate the aerosol results. Moreover, they showed that phage treatment coupled with 
competitive exclusion resulted in even better Salmonella reductions than each of the 
treatments alone (Borie et al., 2009). 
Toro et al. (2005) and coworkers also tested the association of phage therapy and competitive 
exclusion in the treatment of chickens infected experimentally with Salmonella. Phage 
treatment was given orally and included a cocktail of three different phages with different 
host ranges. In all treated groups, with phage or competitive exclusion alone or together, a 
decrease in the Salmonella counts was observed with a reduction to marginal levels in the 
ileum and a six fold reduction in the caeca in the case of the group treated with the phage 
cocktail. Moreover, there was a marginally improved weight gain in the treated animals. 
Although both approaches were able to reduce the Salmonella counts, unlike the previous 
study (Borie et al., 2009) a synergistic effect was not observed (Toro et al., 2005). 
In 2007 Andreatti Filho and colleagues reported on the isolation and testing of two different 
phage cocktails (one with 4 phages and another with 45 phages) in the control of Salmonella 
in vivo and in vitro. In vitro test of these two preparations at concentrations of 105 to 109 
PFU/ml in simulated crop environment resulted in a 1.5 or 5 log10 reduction of Salmonella 
Enteritidis, respectively for the 4-phage and 45-phage cocktails in two hours after treatment. 
Although the 4-phage cocktail did not produce a reduction at six hours post-treatment, the 
45-phage cocktail was able to reduce bacterial counts by 6 log10. This study clearly shows the 
advantage of a cocktail with a large number of phages, probably enabling complementary 
host range between phages and broader action in bacteria. Phage cocktails were 
administered at 108 PFU by oral gavage to day-of-hatch chicks infected with 9x103 CFU of 
Salmonella Enteritidis. These showed significant reduction of Salmonella recovered from 
caecal tonsils after 24 hours of treatment but no difference was observed at 48 hours when 
compared with the control group. Another experiment combined the use of the 45-phage 
cocktail with a commercial probiotic (and controls with each alone) to treat day-of-hatch 
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chicks achieving significant reductions in Salmonella recovery from caecal tonsils at 24 hours 
but no additive or synergistic effect was observed when combining both approaches. Once 
again, phage therapy was only efficient during a short period and no long term protection 
was observed (Andreatti Filho et al., 2007). 
Recently, Wall et al. (2010) tested the efficacy of a cocktail to treat S. Typhimurium 
experimentally infected pigs shortly before processing in order to reduce carcass 
contamination. Administration of the phage at the time of infection resulted in a 2-3 log10 
reduction of Salmonella colonization (Wall et al., 2010). 
O'Flynn et al., (2006) isolated two broad host range Salmonella phages (st104a and st104b) 
which were partially resistant to the porcine gastric juice (pH 2.5). In vitro tests showed a 
reduction of more than 2 log10 in Salmonella numbers in just one hour demonstrating their 
potential in controlling Salmonella in pigs by oral administration. Even so, as seen in other 
studies, for an efficient assessment of their potential as therapeutic agents, in vivo tests are 
needed (O'Flynn et al., 2006). 
 
Target 
pathogen Livestock Results References 
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chicken  Reduction of up to 3 log10 CFU/g in caecal samples 
(Wagenaar et al., 
2005) 
chicken  Reduction of more than 5 log10 CFU in caecal samples 
(Loc Carrillo et 
al., 2005) 
chicken  Reduction of up to 2 log10 CFU/g in caecal samples 
(El-Shibiny et al., 
2009) 
chicken  Reduction of up to 2 log10 CFU/g (faster reduction when administrated in feed) 
(Carvalho et al., 
2010a) 
Sa
lm
on
ell
a 
chicken  Reduction from 60% to 3% in chicken mortality  (Berchieri et al., 1991) 
chicken  Reduction of up to 3.5 log10 CFU/g of caecal content  
(Fiorentin et al., 
2005) 
chicken  Reduction of up to 4.2 log10 CFU of the caecal colonization 
(Atterbury et al., 
2007) 
chicken  Reduction of up to 1.63 log10 CFU/ml in Salmonella recovery from the intestine. 
(Borie et al., 2008; 
Borie et al., 2009) 
chicken  Reduction of up to marginal levels in the ileum and six fold in the caeca in the Salmonella counts
(Toro et al., 
2005) 
chicken  
Reduction of up to 6 log10 in simulated crop 
environment / 55% in recovery from caecal 
tonsils of chicks 
(Andreatti Filho 
et al., 2007) 
pig Reduction of up to 3 log10 reduction of Salmonella colonization 
(Wall et al., 
2010) 
pig Reduction of up to 2 log10 in Salmonella numbers (in vitro test) 
(O'Flynn et al., 
2006) 
Table 1. Studies on phage biocontrol in livestock 
 
Bacteriophages 
 
194 
4.3 Phage biocontrol in food material 
Another way that phages may be used to improve food safety is to apply them directly onto 
raw food products. The practical applicability of this approach may be compromised by the 
minimum density of host cells that are suggested to be required for phage replication (Payne 
et al., 2000; Payne & Jansen, 2001). Nevertheless it was demonstrated that phages can be 
effective biocontrol agents when the population of host cells is as low as 46 CFU/cm2 (Greer, 
1988). These contradictory results may be a consequence of differences in phage/host 
combinations, in the matrix used, in the presence of non-host decoys or even in the models 
applied. Therefore, the efficacy of phage-based biocontrol should be determined on a case-
by-case basis (Atterbury, 2009). 
The application of phages as biocontrol agents has been investigated in a variety of food 
matrices. Nevertheless most studies focus in poultry products, with Campylobacter and 
Salmonella being the most frequently targeted zoonotic pathogens. 
4.3.1 Campylobacter 
Most studies on the use of phages as biocontrol are devoted to pre-harvesting studies. In 
fact, there are only few studies reporting the efficacy of Campylobacter phages in foodstuff.  
Atterbury et al. (2003) studied the survival of C. jejuni and phages on chicken skin at 
temperatures of 4°C or -20°C. A dose of 106 CFU C. jejuni NCTC 12662 PT14 was inoculated 
on the surface of chicken skin and then samples were stored at these two temperatures for a 
period of one hour to ten days (Atterbury et al., 2003a). The results showed that there was a 
reduction of 1 or 2 log10 CFU on Campylobacter counts for skin stored at 4ºC or -20ºC, 
respectively. This reduction was lower than the value normally reported for Campylobacter 
cells stored at -20ºC (3 log10 CFU) (Chan et al., 2001), which indicates that chicken skin may 
have had a protective effect. Phage φ2 at 107 PFU was added to chicken skin samples and 
was show to survive for ten days at 4ºC and at -20 ºC. In order to access whether this phage 
would attach non-specifically to non-susceptible Campylobacter strains at 4ºC, this phage was 
added to C. coli NCTC 12667 at a MOI of 10 for ten days. In fact, Campylobacter counts and 
phage titer did not fall during the experimental period which indicates that a nonspecific 
adsorption did not occur. Conversely when the same phage was added to its susceptible 
host, under the same conditions described above, the Campylobacter numbers were reduced 
by 0.8 log10 CFU/ml (Atterbury et al., 2003a). 
In another experiment performed by the same authors, phage φ2 and C. jejuni NCTC 12662 
PT14 were added to chicken skin samples at different MOI ranging from 10-3 to 105 with 
samples stored at 4ºC and -20ºC for five days. The results again showed a significant 
reduction in Campylobacter counts when the virus were administered at the highest MOI: a 
1.1 log10 to 1.3 log10 CFU reduction in samples stored at 4ºC and a 2.3 log10 to 2.5 log10 CFU 
reduction for frozen samples. Overall, the treatment that showed the best reduction in 
Campylobacter counts in chicken skin was the one in which high phage titers were applied 
following by storage of samples at freezing temperatures. Nevertheless, in all the treatments 
phages were not able to replicate. Furthermore, Campylobacter strains recovered after phage 
treatments were shown to be identical to the inoculated strains and did not display 
resistance to this phage (Atterbury et al., 2003a). 
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Goode et al. (2003) also demonstrated the reduction in Campylobacter levels, after the 
application of a lytic phage to chicken skin, experimentally contaminated with C. jejuni. 
Chicken portions were initially inoculated with 104 CFU/cm2 of C. jejuni strain C222 and 
then half of the chicken pieces were treated with C. jejuni typing phage 12673 at an 
approximate density of 106 PFU/cm2. The samples were incubated at 4ºC and swabs were 
taken after 24h. The results obtained show that Campylobacter counts were reduced by 1.3 
log10 CFU comparing with the control. However, there was even a reduction of 
approximately 1 log10 CFU in the Campylobacter numbers from the non-phage-treated 
chicken portions, which meant that Campylobacter did not survive well on exposed chicken 
surfaces at 4ºC (Goode et al., 2003).  
In 2008 Bigwood et al. (2008) reported on an investigation into the use of phage Cj6 against 
C. jejuni inoculated on cooked and raw meat and incubated for 24h at two different 
temperatures (5ºC and 24ºC) in order to simulate refrigerated and room temperature 
storage. Experiments were performed using different conditions: low (<100 cells/cm2) or 
high (104 cells/cm2) host densities and low (10) or high (104) MOIs. When the experimental 
conditions were set for 5ºC, significant differences were obtained for samples inoculated 
with high MOI and high host density. A reduction of 2.4 log10 CFU/cm2 and 1.5 log10 
CFU/cm2 was obtained on cooked and raw meat, respectively. The titer of phages 
inoculated was also reduced by 10%, after 24h of incubation on cooked meat. When samples 
were stored at 24ºC, at high MOI and low host density, the reduction in Campylobacter 
counts was not significant. However when samples were inoculated at high MOI and high 
host density, reduction of 2.8 log10 CFU/cm2 (after 6h) and 2.2 log10 CFU/cm2 (after 24h) 
were obtained on cooked and raw meat, respectively. Nevertheless, Campylobacter counts 
were reduced, even in the untreated samples, which may be explained by their sensitivity to 
the experimental temperatures. Therefore the results did not allow an accurate assessment 
of the effective reduction by the phage treatment (Bigwood et al., 2008). 
Overall the studies suggest that high MOI values are more effective in the control of 
Campylobacter in foods. From the studies outlined above it is evident that Campylobacter are 
not able to grow and multiply under the conditions found on refrigerated raw meat, which 
renders unlikely phage replication. Nevertheless even if the phage cannot replicate at that 
temperatures, when reaching the human intestine, bacteria increases its metabolic activity 
and phages may eventually attach and lyse the target bacteria, leading to a control effect 
(Goode et al., 2003). 
4.3.2 Salmonella 
Different approaches have been used to assess the effectiveness of phages to control 
pathogens in foodstuff. Salmonella control in poultry products has been constantly 
highlighted. Goode et al. (2003) also used phages to treat chicken skin experimentally 
contaminated with Salmonella Enteritidis (103 CFU/cm2). Different MOIs were tested and for 
a MOI=1 the phages were able to replicate increasing their number with the consequent 
reduction of bacteria by less than 1 log10 in 24 hours. For higher MOIs (102 and 103) the levels 
of recovered Salmonella were reduced by roughly 2 log10 over 48h. Using even a higher MOI 
(105) to treat a more realistic Salmonella contamination level (<102 CFUs) no recoverable 
Salmonella was obtained, resulting in the total elimination of the pathogen (Goode et al., 
2003). 
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The use of phages to reduce contamination of pig skin was studied by Hooton et al. (2011). 
In their study on pig skin artificially contaminated with Salmonella Typhimurium U288 (the 
most prevalent serovar found in pigs) at levels of 103 CFU, a cocktail of four phages which 
included Felix 01 was employed at a temperature of 4ºC. Although the application of the 
phage cocktail at MOI of 1 or less produce little or no reduction, the use of MOI above 10 led 
to a reduction of the pathogen below detectable levels (Hooton et al., 2011).  
The effectiveness of phages to control Salmonella in carcasses of broiler chickens and turkeys 
was tested by Higgins et al. (2005). In this study, 106 PFU of a phage applied to carcasses was 
deemed to be inefficient in the removal of S. Enteritidis at levels below 103. Instead, 
application of  108 PFU resulted in a marked reduction in the numbers of carcasses with 
recoverable Salmonella. Higgins et al. also used a cocktail composed of 72 different Salmonella 
phages to treat naturally contaminated turkey carcasses. The results are promising showing 
that the cocktail effectively reduced Salmonella recovery from the contaminated carcasses. 
These studies suggest that a high concentration of phage, preferably a cocktail of different 
phages, should be used to efficiently treat carcasses contaminated with Salmonella (Higgins 
et al., 2005). 
Control of Salmonella through the action of phages was also tested in raw and cooked beef 
by Bigwood et al. (2008). The samples were inoculated with Salmonella at low or high 
densities (respectively <102 or 104 CFU/cm2). Afterwards, phages were added at a MOI of 
101 or 104 and samples incubated at different temperatures to simulate refrigerated and 
room temperature storage (respectively 5ºC and 24ºC). Phages were able to reduce 
Salmonella counts in up to 2.3 log10 CFU/cm2 for samples incubated at 5ºC and in more than 
5.9 log10 CFU/cm2 for samples incubated at 24ºC when compared to controls (samples 
inoculated with Salmonella without phage). These results were obtained for both high 
densities of Salmonella (104 CFU/cm2) and phages applied at a high MOI (104) with samples 
incubated for 24h. The reductions were even higher after eight days of incubation. For low 
Salmonella densities the reductions were not significant for the majority of the samples. 
Interestingly, recovered Salmonella cells were found to still be sensitive to phage infection 
(Bigwood et al., 2008).  
The well-known broad host range Salmonella phage Felix 01 was used by Whichard et al. 
(2003) to treat chicken sausages contaminated with S. Typhimurium DT104 (300 CFU) and a 
reduction of up to 2.1 log10 in the Salmonella levels was obtained (Whichard et al., 2003). 
Control of Salmonella in foodstuff has not been restricted only to meat and derivates. A 
study carried by Leverentz and colleagues examined the efficiency of phage to control 
Salmonella on fresh-cut fruit, a rapidly developing industry. Treatment with a phage mixture 
was able to reduce the numbers of Salmonella by nearly 3.5 log10 CFU/g in honeydew melon 
slices stored at 5 ºC and 10ºC, temperatures at which Salmonella can survive or increase up to 
2 log10 respectively within a week. At 20ºC, where Salmonella loads can increase up to 5 log10, 
the decrease of Salmonella in slices was of 2.5 log10. The reductions obtained were greater 
than the maximal amount achieved using chemical sanitizers. Although this marked 
reduction in melons, in apple slices this did not happen. The reason may rely in the lower 
pH of apples that does not enables phage survival since it was not possible to reisolate 
phages in the apple 48 hours post treatment while in the melons the phage concentration 
was stable during this time period (Leverentz et al., 2001a).  
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Pao et al. (2004) used phages to treat sprouting seeds where it was found that Salmonella 
grows during soaking. Treatment with phages could reduce the numbers of Salmonella in 
1.37 log10 and 1.5 log10 in mustard seeds and in the soaking water of broccoli seeds by using 
one or two phages respectively (Pao et al., 2004).  
Cheese contamination by Salmonella was also subject of study on possible biocontrol with 
phages. Modi et al. (2001) following standard procedures made cheddar cheese from raw 
and pasteurized milk (an important vehicle of Salmonella transmission to humans) 
(European Food Safety Authority, 2011). The cheese was inoculated with 104 CFU/ml of S. 
Enteritidis and 108 PFU/ml of the Salmonella phage SJ2 (Modi et al., 2001). A decrease in 
Salmonella counts by 1 to 2 log10 was observed in raw and pasteurized milk cheeses while in 
the controls (cheeses made from milks inoculated with only Salmonella and no phage) an 
increase of 1 log10 was observed. After storage of the cheeses for 99 days at 8ºC Salmonella 
was present in the controls at a final concentration of 103 CFU/g. In the phage treated 
cheeses only 50 CFU/g were present in the ones from raw milk and no Salmonella was 
recovered from pasteurized milk cheeses after 89 days. 
Composting is a complex process used not only to obtain a nutrient-rich substrate but also 
to significantly reduce pathogen contamination. Even so, improperly composting may result 
in Salmonella survival and thus constitute a vehicle of Salmonella transmission to animals and 
humans. Heringa et al. (2010) used a cocktail of five phages to treat a dairy manure compost 
inoculated with S. Typhimurium and observed a 2 log10 reduction within four hours and 3 
log10 reduction within 34 hours compared to the controls (Heringa et al., 2010).  
Reduction of Salmonella through the action of phages was also investigated in wastewater. 
Turki et al. (2011) isolated three different phages and tested their ability to reduce Salmonella 
in TSB medium at two temperatures (30ºC and 37ºC). Phages were applied at three different 
MOI (100, 102 and 104) alone or as a cocktail of two or three phages. The three phage cocktail 
was able to reduce all Salmonella cultures at both temperatures when using a high MOI. 
Although, addition of individual or combination of two phages led to the emergence of 
phage resistant bacteria. Even so, the use of two phages presented better results than the use 
of an individual phage. The most important result was the eradication of Salmonella from the 
samples when the three phage cocktail was inoculated in raw wastewater (Turki et al., 2011). 
4.4 Considerations 
The above studies showed inconsistencies in the ability of phages to act as biocontrol agents 
of Campylobacter and Salmonella in livestock. Even so, it seems that the proof of principle, 
that phages are able to reduce the number of these pathogens (at least in a short period after 
treatment), has been established.  
At a first glance, in vivo biocontrol of foodborne pathogens made “on-farm” seems to be a 
good approach since, theoretically, the problem would be treated on its origin. Ideally, 
phages would be applied through the use of a sole administration of a low dose of phage. 
The virulent phage should then amplify at the expense of the target bacteria by repeated 
cycles of replication leading to the host eradication. The increasing number of the progeny 
phage would remain in the system for some period of time acting prophylactically in a 
possible subsequent infection. Although, as shown by several studies, eradication of the 
target bacteria is an extremely unlikely event in part due to the coexistence of a phage- 
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Target 
pathogen Foodstuff Results References 
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chicken skin Reduction of up to 2 log10 on frozen samples 
(Atterbury et 
al., 2003a) 
chicken skin Reduction of up to 2.31 log10 CFU/g at 4ºC. 
(Goode et al., 
2003) 
raw and cooked 
meat 
Reduction of up to 2.8 log10 CFU on 
cooked meat 
(Bigwood et al., 
2008) 
Sa
lm
on
ell
a 
chicken skin Reduction of up to no recoverable Salmonella 
(Goode et al., 
2003) 
pig skin Reduction of up to below detectable levels at 4ºC 
(Hooton et al., 
2011) 
chickens and 
turkeys carcasses 
Reduction of up to 93% reduction in 
Salmonella recovery 
(Higgins et al., 
2005) 
raw and cooked 
meat 
Reduction of more than 5.9 log10 CFU on 
raw meat 
(Bigwood et al., 
2008) 
chicken sausages Reduction of up to 2.1 log10 in the Salmonella levels  
(Whichard et 
al., 2003) 
fresh-cut fruit 
Reduction of up to 3.5 log10 in Salmonella 
numbers in honeydew melon slices 
stored at 5 ºC  
(Leverentz et 
al., 2001b) 
sprouting seeds  Reduction of up to 1.5 log10 in Salmonella numbers 
(Pao et al., 
2004) 
cheese  Reduction of up to no recoverable Salmonella in pasteurized milk cheeses 
(Modi et al., 
2001) 
dairy manure 
compost Reduction of up to 3 log10 
(Heringa et al., 
2010) 
Table 2. Studies on phage biocontrol in foodstuff 
resistant bacterial subpopulation. Eradication is even difficult in vivo since the number of 
Salmonella and Campylobacter is usually higher in broiler chicken intestines than in the 
carcasses and derived products. Moreover, the colonization of animals in herds or flocks 
spreads exponentially and infection may be through direct contact with pens and holding 
facilities which were used before by infected animals. Therefore, the on-farm treatment may 
lead to the emergence of phage resistant strains with their consequent spread to all animals 
in the farm. In addition, repeatedly use of phages may induce production of antibodies that 
will afterwards neutralize the phages, diminishing their effectiveness (Johnson et al., 2008). 
The emergence of phage resistant bacteria is a major concern in phage biocontrol and long 
term studies on the resistance and resistant bacteria should be performed. 
The consistent reduction of the target bacteria shortly after phage administration, and the 
need to avoid the emergence of phage-resistant strains, suggests that phages should be 
applied shortly before slaughter. Indeed, in the period preceding slaughter, the animal is an 
epidemiological endpoint and the phages, as well the bacteria, will be removed from the 
contaminated source. This will prevent the emergence, spread and establishment of phage-
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resistant strains and will not have an impact on the farm microbial balance. Moreover this 
approach constitutes a realistic application of phages enabling the administration of a single 
dose. This will result in a low number of pathogens during food processing with the 
consequent decrease of cross-contamination, contributing thus to the consumer safety. 
Even so, some considerations should be taken into account for an efficient application of 
phages. Phages can be administered by different routes that will have impact in the efficacy 
of the phage action but also economic and practical implications. Obviously, the most 
practical, and probably economical, route of phage application is through food and drinking 
water, at least for large scale treatments as is the treatment of Salmonella and Campylobacter 
in the poultry industry. These routes of administrations will require further studies on the 
dose (volume and concentration) that will be incorporated into food or added to water as 
well the need for a way to protect phages from the low pH of the gastrointestinal tract that 
was shown to often inactivate the majority of phages (Smith et al., 1987a). Protection may be 
enabled through the simultaneously administration of an antacid or through phage proper 
encapsulation as tested by Carvalho et al. (2010) with a Campylobacter phage, phiCcoIBB35 
(Carvalho et al., 2010a), and Ma et al. (2008) with Salmonella phage Felix 01 (Ma et al., 2008), 
respectively. Alternatively, higher phage concentrations and/or phage mutants resistant to 
low pH may be used to increase the efficacy of phage treatment. Intramuscular inoculation 
seems only feasible to treat a low number and/or animals which represent an added value. 
Another important consideration is the need for in vivo studies for each phage in an 
appropriate model able to mimic the system in which the particular phage is to be 
administered since in vitro behaviour usually does not reflects the phage behaviour in vivo, 
in part due to the immune system response. This fact has also been often observed in the 
above studies. 
In the case where phage therapy immediately before slaughter is not possible due to 
inefficiency or impracticability, treatment of meat and foodstuff is also a possible approach. 
When phages are applied in foodstuff (post-slaughter), as in the case of a pre-slaughter 
phage treatment, the emergence of phage-resistant is also prevented since the phages and 
bacterial populations will be removed from the contamination source. Some studies, as 
described above, have addressed the possibility of using phages in the control of foodborne 
pathogens in foodstuff although, the majority of the Salmonella studies were carried at a 
temperature that is the optimum for the target bacteria to grow. This may lead to erroneous 
phage efficacy assessment because phage behaviour is highly dependent on the bacterial 
physiology which in turn also depends on the temperature. Consequently, a reliable study 
should be carried at the same temperature and other conditions at which the foodstuff is 
prepared, processed and/or stored. Commercial storage conditions of carcasses, meat and 
other foodstuff often include a refrigerated temperature of 4ºC in order to halt bacterial 
growth. Experiments performed at this temperature with Campylobacter and Salmonella have 
shown that a relative high dose (high MOI) of phage is needed probably due to the reduced 
host growth that will prevent phage replication. Even so, this is not much different from 
what was observed at higher temperatures or even in studies in livestock where, as it is 
shown here, a high MOI seems to be a requirement to reduce pathogenic loads. The 
presented studies have shown that little or no reduction was observed for MOIs of 1 or less 
suggesting that the therapeutic effect of the phages is passive, without taking advantage of 
their replicating and self-amplification ability. This passive effect of phages is known as 
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“lysis from without” in which the adsorption and attachment of many phages to the 
bacterial surface of a single cell results in lysis without phage replication. The passive effect 
is corroborated by the results of Bigwood et al. (2008) who found that phages did not 
increase in numbers after reducing the Salmonella counts. This passive effect performed by 
the phages is not impaired at temperatures below the minimum for bacterial host growth as 
seen in these experiments performed at 4ºC and 5ºC reinforcing phage application in 
foodstuff at storage conditions (Atterbury et al., 2003a; Bigwood et al., 2008). Moreover, this 
passive effect seems to be less specific than the active one (where phages replicate inside 
their host) as has been observed by Goode et al. (2003) where Salmonella strains resistant to 
phage through restriction were also eliminated by passive effect of phages as long as the 
phages were able to attach (Goode et al., 2003). Consequently, treatment with high MOIs, 
although economically not so attractive due to the need of a higher dose, are able to reduce 
the emergence of phage-resistant strains. 
Another requirement of phage biocontrol is the need for broad host range phages and/or 
the use of a cocktail. Higher reductions in pathogenic bacteria were consistently obtained in 
livestock and foodstuff when a cocktail of phages with complementary host ranges and 
target receptors were used. The advantages of using cocktails and broad host range phages 
will be discussed below.  
Risk analysis modelling have shown that a reduction of 2 log10 in faeces of the slaughtered 
animal or in chicken carcasses can reduce the risk to consumers in 75% or 30 times 
respectively, in the incidence of campylobacteriosis associated with chickens consumption 
(Havelaar et al., 2007; Rosenquist et al., 2003). This 2 log10 reduction was shown in these 
studies to be a possible, practical and realistic goal. 
It can thus be concluded that (by using broad host range phages or cocktails of phages with a 
broad lytic spectrum, applied at high MOI, complemented with in vivo studies) both 
approaches (phage biocontrol in livestock at pre slaughter and in foodstuff) can be used in 
order to decrease the number of pathogenic bacteria in the food chain and consequently to 
reduce the incidence of foodborne diseases caused by Campylobacter and Salmonella. Although 
the studies only address the use of these two strategies separately, and because their 
effectiveness relies in the passive ability of phages to lyse the cells (and thus do not depends on 
the host concentration and physiological state), it can be argued that both approaches can be 
used together in order to achieve higher reductions of the pathogenic bacterial loads. 
5. Prerequisites for an acceptable phage product 
The better understanding of phage biology, infectious process and host-range specificity has 
been tracing the path by which the problems with early phage research may be partially or 
totally solved. Therefore the knowledge acquired so far coupled with the awareness of the 
mistakes committed, should be used to develop phage preparations which should meet 
several criteria whether they are intended to be applied in foodstuff or more importantly in 
animals and humans. Newly isolated phages should always be characterized in detail and 
biocontrol should not be attempted before the biology and genomics of the therapeutic 
phage is well understood. Consequently, the phage host range, virulence, stability and 
interaction with both innate and active immune systems should be determined. 
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5.1 Lytic phages 
In order to assure safety of phage therapy and eliminate potential risks of failure or even 
complications, it is critical that phages used in therapy are strictly lytic and without: 
transducing capabilities, gene sequences having significant homology with known major 
antibiotic resistance genes, genes for toxins and genes for other bacterial virulence factors 
(Carlton et al., 2005). Consequently, it is critical to avoid temperate phages. Reasons for this 
discrimination involve the fact that the latter phages will not kill all the target bacteria due 
to their ability to lysogenize them and probably more important, there is a high risk of 
possessing genes that can render the bacteria more virulent (Los et al., 2010). This can 
happen because certain temperate phages, such as those associated with Staphylococcus, E. 
coli, Salmonella, Corynebacterium and Clostridium actually carry virulence genes. In addition, 
during the transition between the lysogenic cycle and the lytic cycle, the excision of the 
prophage DNA may be accompanied with small pieces of the bacterial genome thus 
producing a specialized transducing phage. In addition, certain viruses such as Salmonella 
phage P22 are generalized transducers that are capable of randomly packaging any part of 
the host genome. Transducing phages will then transfer the host DNA fragments to newly 
infected bacteria producing changes in the bacterial genomes through recombination or 
reintegration. This may produce undesired phenotypic changes in their hosts such as 
resistance to antibiotics, restriction systems and increased bacterial virulence such as: 
bacterial adhesion, colonization, invasion and spread through human tissues, resistance to 
immune defences and exotoxin production (e.g. cholera toxin encoded by Vibrio cholerae-
phage CTX) (Los et al., 2010; Waldor & Mekalanos, 1996). Strictly lytic phages usually do not 
pose these risks but should be tested for transducing (Waddell et al., 2009). 
5.2 Cocktails and broad-host-range phages 
Within a given bacterial pathogen different mutants may exist with different susceptibility 
for a given phage. Although therapy should always match the phage with the target bacteria 
there are situations where treatment is urgently need, turning that approach impossible. 
Moreover, bacterial pathogens may mutate during the treatment time period and become 
resistant to the phage. This risk is real in part due to the narrow host range of phages. A way 
to circumvent these problems is by using a cocktail of phages targeting different receptors in 
the pathogen cell and with cross-resistant lytic activity. Consequently, if a bacterium is, or 
stays, resistant to one phage it is likely that it would not be resistant to a second phage 
which is immediately available in the cocktail and that targets a different receptor. This 
approach has been successfully used by Smith et al. (1987) in their E. coli diarrhoeal work 
(Smith et al., 1987b). 
An alternative to the phage cocktails is the use of broad host range phages that can be 
isolated through the use of common ubiquitous receptors in the target bacteria as in the case 
of phages that recognize TolC. In Salmonella this outer membrane protein is involved in the 
adhesion and invasion of host intestinal epithelial cells (Ricci & Piddock, 2010). Broad host 
range phages are polyvalent phages capable of infecting across bacterial species or genera 
and thus able to infect the majority of the target bacteria. These phages present a huge 
advantage as therapeutic agents and from the biotechnological point of view they are much 
more attractive because a single phage is far easier to characterize and get approved by the 
regulatory authorities. The existence of such polyvalent phages in nature is rare and only a 
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few of them are known. Examples include Salmonella phage Felix O1 which infects most 
Salmonella serovars (Kallings, 1967) and Salmonella phage PVP-SE1 which presents a lytic 
spectrum even broader than that of Felix 01 (Santos et al., 2010). Nevertheless these phages 
may present a drawback if they are able to target other non-pathogenic bacteria causing 
dysbiosis. Therefore the ideal phage for use as biocontrol agent should have a broad host 
range among the target pathogen without infecting the commensal flora. Examples of these 
phages include two virulent coliphages which were able to lyse a high percentage of 
pathogenic E. coli strains of various serotypes whilst showed low lytic ability to lyse non-
pathogenic E. coli strains (Viscardi et al., 2008). These broad host range phages may also be 
used, not only as alternatives to cocktails, but also to design new cocktails with broader host 
ranges and consequently more efficient. Furthermore, phage cocktails and broad host range 
phages will also combat and prevent the emergence of phage resistant strains. Another 
possibility would be to engineer phages in order to target numerous receptors. Although 
very interesting and promising from a scientific point of view, this approach would hardly 
get acceptance from the food authorities (Kropinski, 2006). 
5.3 Genome sequencing 
A full knowledge of phage genome sequences is important to ensure that the phage does not 
carry obvious virulence factors, resistance or lysogeny genes. The identification of gene 
homologies requires detailed bioinformatics analysis. The latter is essential to evaluate 
possible complications that might arise during phage therapy. It was suggested that data 
from phage genome sequences could be used to establish a bank of “safe” therapeutic 
phages increasing the availability, safety and efficacy of phage therapy (Petty et al., 2007). 
Phages that break down the bacterial DNA to recycle bacterial host genome for their own 
DNA synthesis should be selected for therapy since this will hamper coexistence between 
phage and host. Such phages usually encode enzymes involved in nucleotide metabolism 
and the corresponding genes can be identified through sequence analysis (Carlton et al., 
2005). Even so, due to the usually high number of genes in the phage genome with 
unknown function, it is never possible to assure at 100% that no virulence factors, resistance 
or lysogeny genes exist. Correspondingly, the genome sequencing analysis enables to reject 
the use of phages for which genes were found to code for virulence, resistance or lysogeny 
but that does not present any experimental biologic evidence of it, that is, which never have 
shown to lysogenize a bacterium or increase the bacterium virulence and/or resistance. 
5.4 Models for host-phage interaction 
Phage therapy experimental design is not straightforward due to the self-replicating nature of 
phages. This means that for each phage, pharmacokinetic information is required which can be 
achieved by the determination of the phage infection parameters and by the use of a reliable 
population dynamic model able to predict the phage-bacteria behaviour. Understanding these 
dynamics will help the transference of in vitro results to in vivo predictions, explaining why a 
phage that replicates extremely well in the target bacteria in vitro fails to do it in vivo. It is 
expected that mathematical models may help to design experimental studies of population 
dynamics by identifying and evaluating the relative contribution of phage and bacteria in the 
course and outcome of an infection (Levin & Bull, 2004). Therefore, in vivo assessment of the 
phage, in a suitable animal model, should always be accomplished.  
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5.5 Phage production in a large-scale and storage 
The increasing interest in phages as therapeutic or biocontrol agents and the intention of 
commercially distribute a phage or a phage based product demands a large scale production 
that is not compatible with the conventional double-agar overlay method. Consequently, 
production of phages will certainly make use of bioreactors and a control and optimization 
of phage production will play an important role. Good manufacturing practice requirements 
demands for the development of methods that ensure phage preparations highly purified, 
free of bacteria, toxins, pyrogenic substances and other harmful components. Although in 
the majority of animal studies phages were administered as crude lysates without adverse 
effects for the animal, the removal of endotoxins, exotoxins and cell debris is very important 
for the safety of the phage product and also for an easier acceptance by the consumers. An 
option would be the propagation of phages in a non-pathogenic or in a non-toxin producer 
host (Santos et al., 2010). The storage should also be validated and suitable for the particular 
phage in order to assure that the preparations contain viable phage particles able to infect 
the target bacteria. Moreover, stability and pH control of the preparation is important as 
shown in the past by the rising problems observed when these facts were neglected 
(Merabishvili et al., 2009). 
6. Commercialization of phage-based products 
Despite the good scientific results and the economic viability of phage products an 
important issue that cannot be forgotten is the public acceptance which can constitute a 
serious obstacle to the introduction of phages in food. It is likely that consumers will feel an 
antipathy when knowing that live viruses are being added in their foods and that will be 
ingested by them. First of all, phages are viruses that only infect bacteria and not eukaryotic 
cells as the human cells. Moreover they are very specific to the target bacteria avoiding this 
way dysbiosis. It is also important to note that the use of a virus to combat a pathogen is not 
so strange since some vaccinations are carried out using live, albeit attenuated, eukaryotic 
viruses. Since phages have been identified in drinking water, and foods such a yoghurt and 
salami they are generally considered safe (Rohwer, 2003). Also, this means not only that 
phages are already inside our body but also that they are constantly being ingested. 
Different phages, applied at different doses, using different routes of administration in 
humans during the long history of phage therapy in the Eastern Europe did not produced 
serious complications (Sulakvelidze et al., 2001). Moreover, in a carefully controlled double-
blind study involving ingestion of phage T4 by volunteers, no side effects were reported 
(Bruttin & Brussow, 2005). These facts show that phages are nontoxic to animals and plants 
and apparently innocuous from a clinical standpoint. Along these lines, it can be conclude 
that the introduction of phages in human food-chain through the usage of phages as 
biocontrol agents in living animals or carcases can be considered safe and may be seen as a 
valuable alternative to the use of antibiotics in animal production. 
With respect to regulations, the introduction of a biocontrol phage product in animals and 
foodstuff may not be as stringent as its introduction in human therapy. The way for its 
introduction has been recently (2006) paved by the approval by the American Food and Drug 
Administration (FDA) of a mixed Listeria-phage preparation, ListShield (www.intralytix.com) 
to be used as a food additive in poultry derivatives and ready-to-eat meat. Another product 
based on a Listeria-phage, Listex P-100 (www.micreosfoodsafety.com), has received the status 
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“generally recognized as safe” (GRAS) to be used in all food products in 2007. Other phage-
based products to control E. coli and Salmonella exist to be used at pre-slaughter 
(www.omnilytics.com and www.intralytix.com). The approval of such products proves the 
safety of phages and anticipates the development and introduction of new phage based 
products to be applied not only in foodstuff but also, at a long term, in animals and humans.  
7. Conclusions 
The emergence of multidrug-resistant bacteria has opened a second window for phage 
biocontrol. The recent work reviewed here shows that it has been established the proof-of-
principle and evidences are more than enough to state that phage biocontrol, if well-
conceived, is very effective in the treatment and prophylaxis of many problematic infectious 
diseases. Of particular interest is the potential that phage biocontrol has demonstrated 
against the global problematic multidrug-resistant bacteria. While the results of phage based 
products efficacy are very promising some consideration need to be taken into account. 
Efficient phage biocontrol requires the use of broad host range phages and administration of 
cocktails of phages with complementary host ranges and target receptors (showing thus 
cross-resistant lytic activity) in order to circumvent the emergence of phage resistant 
bacteria. Also, in vivo studies with suitable models should always be performed to assess the 
efficacy of the phage based product. From an economical and practical point of view, the 
best route of administration at an industrial scale is obviously through food and drinking 
water. For a successful application of phages it is important to understand the epidemiology 
of the pathogen against which the phage preparation is to be used in order to identify the 
critical intervention points in the processing cycle where phage application would be most 
beneficial. On the other hand, consistent pathogenic bacteria reduction is only achieved 
short after phage administration suggesting that phages should be applied in livestock 
shortly before slaughter and/or post-slaughter in carcasses and foodstuff. Besides reducing 
significantly the bacterial loads in the food chain with the consequent reduction in 
foodborne incidences it will impair the emergence of phage resistant bacteria. 
Finally, although the consumers may be reluctant to the introduction of phages in the food 
chain, they have already shown to be safe for the environment, animals and humans with 
high efficiency in the reduction of foodborne pathogens. Moreover, some phage products 
are already commercially available and thus the way for the introduction of new phage 
based products is now open. 
Overall, it can be concluded that phages can and should be used, not only as alternative, but 
also as substitutes of antibiotics and chemical antibacterials, in the control of foodborne 
pathogens in livestock and foodstuff. 
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